These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23831869)

  • 1. The association between CYP2D6 genotype and switching antipsychotic medication to clozapine.
    Gregoor JG; van der Weide K; van der Weide J; van Megen HJ; Egberts AC; Heerdink ER
    Eur J Clin Pharmacol; 2013 Nov; 69(11):1927-32. PubMed ID: 23831869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.
    Jukic MM; Smith RL; Haslemo T; Molden E; Ingelman-Sundberg M
    Lancet Psychiatry; 2019 May; 6(5):418-426. PubMed ID: 31000417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice.
    Mulder H; Herder A; Wilmink FW; Tamminga WJ; Belitser SV; Egberts AC
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):107-14. PubMed ID: 16294366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patients.
    Melkersson KI; Scordo MG; Gunes A; Dahl ML
    J Clin Psychiatry; 2007 May; 68(5):697-704. PubMed ID: 17503978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study.
    Schillevoort I; de Boer A; van der Weide J; Steijns LS; Roos RA; Jansen PA; Leufkens HG
    Pharmacogenetics; 2002 Apr; 12(3):235-40. PubMed ID: 11927839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.
    Aitchison KJ; Munro J; Wright P; Smith S; Makoff AJ; Sachse C; Sham PC; Murray RM; Collier DA; Kerwin RW
    Br J Clin Pharmacol; 1999 Sep; 48(3):388-94. PubMed ID: 10510151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the medication pattern reflect the CYP2D6 genotype in patients with diagnoses within the schizophrenic spectrum?
    Jürgens G; Rasmussen HB; Werge T; Dalhoff K; Nordentoft M; Andersen SE
    J Clin Psychopharmacol; 2012 Feb; 32(1):100-5. PubMed ID: 22198443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 2D6 polymorphism and its impact on decision-making in psychopharmacotherapy: finding the right way in an ultrarapid metabolizing patient.
    Paulzen M; Tauber SC; Kirner-Veselinovic A; Gründer G
    J Clin Psychiatry; 2011 Nov; 72(11):1465-7. PubMed ID: 22127193
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
    Dahl ML
    Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.
    Chou WH; Yan FX; de Leon J; Barnhill J; Rogers T; Cronin M; Pho M; Xiao V; Ryder TB; Liu WW; Teiling C; Wedlund PJ
    J Clin Psychopharmacol; 2000 Apr; 20(2):246-51. PubMed ID: 10770465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P4502D6 genotype does not determine response to clozapine.
    Arranz MJ; Dawson E; Shaikh S; Sham P; Sharma T; Aitchison K; Crocq MA; Gill M; Kerwin R; Collier DA
    Br J Clin Pharmacol; 1995 Apr; 39(4):417-20. PubMed ID: 7640149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
    van der Weide K; van der Weide J
    J Clin Psychopharmacol; 2015 Jun; 35(3):228-36. PubMed ID: 25868121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients.
    Mannheimer B; Holm J; Koukel L; Bertilsson L; Osby U; Eliasson E
    Eur J Clin Pharmacol; 2014 Jun; 70(6):695-9. PubMed ID: 24643635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.
    Ivashchenko DV; Yudelevich DA; Buromskaya NI; Shimanov PV; Deitch RV; Akmalova KA; Kachanova AA; Dorina IV; Nastovich MI; Grishina EA; Savchenko LM; Shevchenko YS; Sychev DA
    Drug Metab Pers Ther; 2021 Aug; 37(1):47-53. PubMed ID: 35385893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype.
    Armstrong M; Daly AK; Blennerhassett R; Ferrier N; Idle JR
    Br J Psychiatry; 1997 Jan; 170():23-6. PubMed ID: 9068770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of several antipsychotics and antidepressants due to a pharmacogenetic cause: a case report.
    Mian P; Somers M; Berg MT; Cahn W; Wilting I; Schaik RV
    Pharmacogenomics; 2019 Jun; 20(8):567-570. PubMed ID: 31190622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.